Suvretta Capital Management, LLC has filed its 13F form on February 14, 2025 for Q4 2024 where it was disclosed a total value porftolio of $2.4 Billion distributed in 96 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Arcutis Biotherapeutics, Inc. with a value of $159M, Intra Cellular Therapies, Inc. with a value of $120M, Legend Biotech Corp with a value of $114M, Insmed Inc with a value of $111M, and Meta Platforms, Inc. with a value of $100M.
Examining the 13F form we can see an decrease of $140M in the current position value, from $2.54B to 2.4B.
Suvretta Capital Management, LLC is based out at New York, NY
Below you can find more details about Suvretta Capital Management, LLC portfolio as well as his latest detailed transactions.
Portfolio value
$2.4 Billion
Healthcare: $1.22 Billion
Consumer Cyclical: $262 Million
Technology: $259 Million
ETFs: $205 Million
Financial Services: $164 Million
Communication Services: $141 Million
Industrials: $80.4 Million
Consumer Defensive: $70.8 Million
Other: $1.51 Million
Stock Holdings Table Market Cap. of $10 Billions to $200 Billions
